Videos
TTP develops dose counter for AstraZeneca’s Symbicort® inhaler
Identifying risks early in the product development process is crucial for ensuring smooth, surprise-free project outcomes when scaling drug delivery devices. Iain McDerment outlines the first-principles approach to the R&D process, applying rigorous modelling and experimentation to reduce risks – rapidly developing a highly reliable, safety-critical dose counter.
Talk to us about your next project
Last Updated
May 5, 2023
Talk to us about your next project
We help clients with all stages of their most complex and challenging technology and product development projects.
If you're considering the next steps along your innovation journey, why not get in touch?
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
